A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
Slovak
M L
ML
Gundacker
H
H
Bloomfield
C D
CD
Dewald
G
G
Appelbaum
F R
FR
Larson
R A
RA
Tallman
M S
MS
Bennett
J M
JM
Stirewalt
D L
DL
Meshinchi
S
S
Willman
C L
CL
Ravindranath
Y
Y
Alonzo
T A
TA
Carroll
A J
AJ
Raimondi
S C
SC
Heerema
N A
NA
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002896:Chromosomes, Human, Pair 6; D002899:Chromosomes, Human, Pair 9; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000145:classification / Q000235:genetics* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011379:Prognosis; D011446:Prospective Studies; D012189:Retrospective Studies; D014178:Translocation, Genetic